TCM
TEVA icon

Tran Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

Tran Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-41,585
Closed -$2.2M – 109
2014
Q1 		$2.2M Sell
41,585
-64,307
-61% -$2.97M 0.04% 76
2013
Q4 		$4.24M Sell
105,892
-12,822
-11% -$505K 0.07% 60
2013
Q3 		$4.49M Buy
118,714
+3,774
+3% +$147K 0.09% 53
2013
Q2 		$4.51M Buy
+114,940
New +$4.48M 0.1% 47

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Tran Capital Management's TEVA Position: Q2 2014 in Review

Tran Capital Management sold out of Teva Pharmaceuticals (TEVA) in Q2 2014, closing a stake of 41,585 shares — an estimated $2.2M sold.

Tran Capital Management first reported a position in TEVA in Q2 2013 and held it in 4 quarters. The position peaked at $4.51M in Q2 2013. 779 funds tracked by Wall St. Rank hold TEVA as of Q2 2014.

  • Tran Capital Management reported no remaining Teva Pharmaceuticals position as of Q2 2014 after selling out during the quarter.
  • Tran Capital Management sold 41,585 Teva Pharmaceuticals shares in Q2 2014, an estimated $2.2M.
  • Tran Capital Management first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 4 quarters.
  • Tran Capital Management's Teva Pharmaceuticals position peaked at $4.51M in Q2 2013.
  • 779 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2014.

Based on Tran Capital Management's 13F filing for Q2 2014, filed 29 Jul 2014.